Folgen
Anna Bonjoch
Anna Bonjoch
Zugehörigkeit unbekannt
Bestätigte E-Mail-Adresse bei flsida.org
Titel
Zitiert von
Zitiert von
Jahr
Prospective randomized two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy
A Tuldrà, CR Fumaz, MJ Ferrer, R Bayés, A Arnó, M Balagué, A Bonjoch, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 25 (3), 221-228, 2000
3452000
Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients
C Tural, J Romeu, G Sirera, D Andreu, M Conejero, S Ruiz, A Jou, ...
Journal of Infectious Diseases 177 (4), 1080-1083, 1998
2381998
Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and …
E Negredo, L Cruz, R Paredes, L Ruiz, CR Fumaz, A Bonjoch, S Gel, ...
Clinical infectious diseases 34 (4), 504-510, 2002
2302002
High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study
A Bonjoch, M Figueras, C Estany, N Perez-Alvarez, J Rosales, L del Rio, ...
Aids 24 (18), 2827-2833, 2010
2142010
Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with HIV-associated lipodystrophy: 1-year prospective follow-up of a …
L Ruiz, E Negredo, P Domingo, R Paredes, E Francia, M Balagué, S Gel, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 27 (3), 229-236, 2001
2142001
Quality of life, emotional status, and adherence of HIV-1-infected patients treated with efavirenz versus protease inhibitor-containing regimens
CR Fumaz, A Tuldra, MJ Ferrer, R Paredes, A Bonjoch, T Jou, E Negredo, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 29 (3), 244-253, 2002
1972002
Non-nucleoside reverse transcriptase inhibitor resistance among patients failing a nevirapine plus protease inhibitor-containing regimen
JL Casado, K Hertogs, L Ruiz, F Dronda, A Van Cauwenberge, A Arnó, ...
Aids 14 (2), F1-F7, 2000
1082000
Role of structured treatment interruption before a 5-drug salvage antiretroviral regimen: the Retrogene Study
L Ruiz, E Ribera, A Bonjoch, J Romeu, J Martinez-Picado, R Paredes, ...
The Journal of infectious diseases 188 (7), 977-985, 2003
1042003
Ezetimibe, a promising lipid-lowering agent for the treatment of dyslipidaemia in HIV-infected patients with poor response to statins
E Negredo, J Molto, J Puig, D Cinquegrana, A Bonjoch, N Perez-Alvarez, ...
Aids 20 (17), 2159-2164, 2006
992006
Hypophosphatemic osteomalacia induced by tenofovir in HIV-infected patients
L Mateo, S Holgado, ML Mariñoso, R Pérez-Andrés, A Bonjoch, J Romeu, ...
Clinical rheumatology 35, 1271-1279, 2016
962016
High rate of reversibility of renal damage in a cohort of HIV-infected patients receiving tenofovir-containing antiretroviral therapy
A Bonjoch, P Echeverría, N Perez-Alvarez, J Puig, C Estany, B Clotet, ...
Antiviral research 96 (1), 65-69, 2012
632012
Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine …
E Negredo, O Miró, B Rodríguez-Santiago, G Garrabou, C Estany, ...
Clinical Infectious Diseases 49 (6), 892-900, 2009
612009
High prevalence of sarcopenia in HIV-infected individuals
P Echeverría, A Bonjoch, J Puig, C Estany, A Ornelas, B Clotet, ...
BioMed research international 2018, 2018
582018
Improvement in bone mineral density after switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: two-centre randomized pilot study …
E Negredo, P Domingo, N Pérez-Álvarez, M Gutiérrez, G Mateo, J Puig, ...
Journal of Antimicrobial Chemotherapy 69 (12), 3368-3371, 2014
572014
Long-term safety and efficacy of nevirapine-based approaches in HIV type 1-infected patients
A Bonjoch, R Paredes, P Domingo, M Cervantes, E Pedrol, E Ribera, ...
AIDS Research & Human Retroviruses 22 (4), 321-329, 2006
542006
Benefits and concerns of simplification strategies in HIV-infected patients
E Negredo, A Bonjoch, B Clotet
Journal of Antimicrobial Chemotherapy 58 (2), 235-242, 2006
502006
Genetic evolution of gp41 reveals a highly exclusive relationship between codons 36, 38 and 43 in gp41 under long-term enfuvirtide-containing salvage regimen
C Cabrera, S Marfil, E García, J Martinez-Picado, A Bonjoch, M Bofill, ...
Aids 20 (16), 2075-2080, 2006
482006
Condylomata, cytological abnormalities and human papillomavirus infection in the anal canal in HIV‐infected men
L Darwich, MP Cañadas, S Videla, J Coll, M Piñol, P Cobarsi, ...
HIV medicine 13 (9), 549-557, 2012
432012
Validation of estimated renal function measurements compared with the isotopic glomerular filtration rate in an HIV-infected cohort
A Bonjoch, B Bayés, J Riba, J Puig, C Estany, N Perez-Alvarez, B Clotet, ...
Antiviral research 88 (3), 347-354, 2010
432010
Peak bone mass in young HIV-infected patients compared with healthy controls
E Negredo, P Domingo, E Ferrer, V Estrada, A Curran, A Navarro, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 65 (2), 207-212, 2014
422014
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20